Chemical Structure : Chiauranib
CAS No.: 1256349-48-0
货号: PC-20795Not For Human Use, Lab Use Only.
Chiauranib (Ibcasertib, CS2164) is a potent multi-kinase inhibitor, inhibits VEGFR2, Aurora B and CSF-1R kinases with IC50 values of 7, 9 and 7 nM, respectively.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥1280 | In stock | |
10 mg | ¥1980 | In stock | |
25 mg | ¥3480 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Chiauranib (Ibcasertib, CS2164) is a potent multi-kinase inhibitor, inhibits VEGFR2, Aurora B and CSF-1R kinases with IC50 values of 7, 9 and 7 nM, respectively.
CS2164 interacts with each active ATP-binding pocket of VEGFR2, Aurora B and CSF-1R kinases, respectively.
CS2164 also displays inhibitory activities with single digital nanomolar IC50 against several angiogenesis-related kinases, including VEGFR1, VEGFR3, PDGFRα and c-Kit.
CS2164 only shows moderate inhibitory activities (100 nM < IC50 < 500 nM) in 4 kinases (c-RAF, DDR2, PLK1 and PLK3), little activity (IC50 > 500 nM) in 33 kinases, and almost no activity (IC50 > 10 μM) in over 120 kinases, including 76 GPCR and 8 ion channels tested.
CS2164 potently inhibits VEGF-induced proliferation of HUVEC cells and PDGF‐induced proliferation of NIH-3T3 cells with GI50 values of 20.70 and 44.16 nM, respectively.
CS2164 is a potent inhibitor of tumor angiogenesis through targeting the corresponding tyrosine receptor signaling pathways, induces G2/M cell cycle arrest by inhibition of Aurora B/p-H3.
CS2164 inhibits CSF-1R signaling and reduces tissue CSF-1R expression.
CS2164 exhibits broad and potent in vivo anti-tumor activities, CS2164 (40 mg/kg) induces dose-dependent inhibition of tumor growth in human non‐small cell lung cancer cell line A549-derived xenograft model.
分子量 | 435.48 | |
分子式 | C27H21N3O3 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
N-(2-aminophenyl)-6-[(7-methoxy-4-quinolinyl)oxy]-1-naphthalenecarboxamide |
1. Zhou Y, et al. Cancer Sci. 2017 Mar;108(3):469-477.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright